Expert Consensus on Patient Derived Tumor Organoid Culture and Drug Sensitivity Testing

Mon, 04 Nov 2024 00:00:00 +0800

The precision treatment of cancer has consistently been a significant issue in clinical management as well as medical research. With the rapid development and advances towards clinical application of organoids technology, the use of organoids derived from both normal and cancer tissues for pathophysiology studies, treatment regimen development, and drug screening has become increasingly prevalent. This document compiles insights from dozens of nationwide experts and scholars in the field of tumor organoids drug sensitivity testing. It discusses the entire process of tumor organoids drug sensitivity testing, with the intent to provide expert guidance for laboratories interested in conducting clinical testing and application research related to cancer precision therapy.

Journal of Organoid and Bioscience

Expert Consensus on Patient Derived Tumor Organoid Culture and Drug Sensitivity Testing